Global pharmaceutical giant Sandoz is undergoing a profound strategic evolution, shifting its long-term commercial anchor away from traditional small-molecule generics…
Read More

Global pharmaceutical giant Sandoz is undergoing a profound strategic evolution, shifting its long-term commercial anchor away from traditional small-molecule generics…
Read More
The 2026 Association of Biomolecular Resource Facilities (ABRF) Annual Meeting, held in Pittsburgh, PA, USA, from March 28–31, once again…
Read More
In a significant pivot from the traditional aesthetics market, Rubedo Life Sciences, under the leadership of CEO Dr. Frederick Beddingfield…
Read More